The repertoires of peptides presented by MHC-II in the thymus and in peripheral tissue: A clue for autoimmunity?

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Collado, Javier A ^a   Guitart, Carolina ^a   Teresa Ciudad, M ^a   Alvarez, Iñaki ^a   Jaraquemada, Dolores ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Human; MHC II; Peptide repertoire; Peripheral tissues; Thymus

Indexed keywords

EID: 84892166628     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00442     Document Type: Short Survey

References (75)

1. Kourilsky P, Claverie JM. MHC restriction, alloreactivity, and thymic education: a common link? Cell (1989) 56:327-9. doi: 10.1016/0092-8674(89)90233-X.
2. Stoeckle C, Quecke P, Rückrich T, Burster T, Reich M, Weber E, et al. Cathepsin S dominates autoantigen processing in human thymic dendritic cells. J Autoimmun (2012) 38:332-43. doi:10.1016/j.jaut.2012.02.003.
3. Stoeckle C, Sommandas V, Adamopoulou E, Belisle K, Schiekofer S, Melms A, et al. Cathepsin G is differentially expressed in primary human antigen-presenting cells. Cell Immunol (2009) 255:41-5. doi:10.1016/j.cellimm.2008.10.001.
4. Marrack P, Ignatowicz L, Kappler JW, Boymel J, Freed JH. Comparison of peptides bound to spleen and thymus class II. J Exp Med (1993) 178:2173-83. doi:10.1084/jem.178.6.2173.
5. Collado JA, Alvarez I, Ciudad MT, Espinosa G, Canals F, Pujol-Borrell R, et al. Composition of the HLA-DR-associated human thymus peptidome. Eur J Immunol (2013) 43:2273-82. doi:10.1002/eji.201243280.
6. Douek DC, Altmann DM. T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus. Immunology (2000) 99:249-56. doi:10.1046/j.1365-2567.2000.00940.x.
7. Koble C, Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med (2009) 206:1505-13. doi:10.1084/jem.20082449.
8. Hadeiba H, Butcher EC. Thymus-homing dendritic cells in central tolerance. Eur J Immunol (2013) 43:1425-9. doi:10.1002/eji.201243192.
9. Gray D, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med (2007) 204:2521-8. doi:10.1084/jem.20070795.
10. Colomé N, Collado J, Bech-Serra JJ, Liiv I, Antón LC, Peterson P, et al. Increased apoptosis after autoimmune regulator expression in epithelial cells revealed by a combined quantitative proteomics approach. J Proteome Res (2010) 9:2600-9. doi:10.1021/pr100044d.
11. Liiv I, Haljasorg U, Kisand K, Maslovskaja J, Laan M, Peterson P. AIRE-induced apoptosis is associated with nuclear translocation of stress sensor protein GAPDH. Biochem Biophys Res Commun (2012) 423:32-7. doi:10.1016/j.bbrc.2012.05.057.
12. Adamopoulou E, Tenzer S, Hillen N, Klug P, Rota IA, Tietz S, et al. Exploring the MHC-peptide matrix of central tolerance in the human thymus. Nat Commun (2013) 4:2039. doi:10.1038/ncomms3039.
13. Espinosa G, Collado JA, Scholz E, Mestre-Ferrer A, Kuse N, Takiguchi M, et al. Peptides presented by HLA class I molecules in the human thymus. J Proteomics (2013) 94C:23-36. doi:10.1016/j.jprot.2013.08.023.
14. Muntasell A, Carrascal M, Alvarez I, Serradell L, van Veelen P, Verreck FAW, et al. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J Immunol (2004) 173:1085-93.
15. Sadegh-Nasseri S, Chou C-L, Hartman IZ, Kim A, Narayan K. How HLA-DM works: recognition of MHC II conformational heterogeneity. Front Biosci (Schol Ed) (2012) 4:1325-32. doi:10.2741/S334.
16. Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, et al. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Immunity (2005) 23:29-40. doi:10.1016/j.immuni.2005.05.009.
17. Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S. NetMHCIIpan-2.0-improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res (2010) 6:9. doi:10.1186/1745-7580-6-9.
18. Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature (2008) 455:396-400. doi:10.1038/nature07208.
19. Aichinger M, Wu C, Nedjic J, Klein L. Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J Exp Med (2013) 210:287-300. doi:10.1084/jem.20122149.
20. Klein L, Roettinger B, Kyewski B. Sampling of complementing self-antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur J Immunol (2001) 31:2476-86. doi:10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T.
21. Kyewski B, Derbinski J. Self-representation in the thymus: an extended view. Nat Rev Immunol (2004) 4:688-98. doi:10.1038/nri1436.
22. Bozzacco L, Yu H, Zebroski HA, III, Dengjel J, Deng H, Mojsov S, et al. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res (2011) 10:5016-30. doi:10.1021/pr200503g.
23. Muixí L, Carrascal M, Alvarez I, Daura X, Martí M, Armengol MP, et al. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J Immunol (2008) 181:795-807.
24. Fissolo N, Haag S, de Graaf KL, Drews O, Stevanovic S, Rammensee HG, et al. Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol Cell Proteomics (2009) 8:2090-101. doi:10.1074/mcp.M900001-MCP200.
25. Seward RJ, Drouin EE, Steere AC, Costello CE. Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol Cell Proteomics (2011) 10:M110.002477. doi:10.1074/mcp.M110.002477.
26. Dengjel J, Nastke M-D, Gouttefangeas C, Gitsioudis G, Schoor O, Altenberend F, et al. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas. Clin Cancer Res (2006) 12:4163-4170. doi:10.1158/1078-0432.CCR-05-2470.
27. Baggio MC, Medeiros-Neto G, Osawa Y, Nguyen NY, Santisteban P, Knobel M, et al. Amino acid composition of proteins extracted from endemic goiter glands. Endocr Pathol (1996) 7:137-43. doi:10.1007/BF02739973.
28. Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, et al. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol (2004) 229:79-85. doi:10.1016/j.cellimm.2004.07.002.
29. Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, Stefan M, et al. Tg.2098 is a major human thyroglobulin T-cell epitope. J Autoimmun (2010) 35:45-51. doi:10.1016/j.jaut.2010.01.004.
30. Tolosa E, Li W, Yasuda Y, Wienhold W, Denzin LK, Lautwein A, et al. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Invest (2003) 112:517-26. doi:10.1172/JCI200318028.
31. Burster T, Beck A, Tolosa E, Schnorrer P, Weissert R, Reich M, et al. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. J Immunol (2005) 175:5940-9.
32. Hsing LC, Kirk EA, McMillen TS, Hsiao S-H, Caldwell M, Houston B, et al. Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. J Autoimmun (2010) 34:96-104. doi:10.1016/j.jaut.2009.07.003.
33. Jordans S, Jenko-Kokalj S, Kühl NM, Tedelind S, Sendt W, Brömme D, et al. Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions. BMC Biochem (2009) 10:23. doi:10.1186/1471-2091-10-23.
34. Shuja S, Cai J, Iacobuzio-Donahue C, Zacks J, Beazley RM, Kasznica JM, et al. Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters. Thyroid (1999) 9:569-77. doi:10.1089/thy.1999.9.569.
35. Reddy VB, Shimada SG, Sikand P, Lamotte RH, Lerner EA. Cathepsin S elicits itch and signals via protease-activated receptors. J Invest Dermatol (2010) 130:1468-70. doi:10.1038/jid.2009.430.
36. Yasuda Y, Kaleta J, Brömme D. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev (2005) 57:973-93. doi:10.1016/j.addr.2004.12.013.
37. Villaseñor J, Besse W, Benoist C, Mathis D. Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated. Proc Natl Acad Sci U S A (2008) 105:15854-9. doi:10.1073/pnas.0808069105.
38. Geenen V. Thymus and type 1 diabetes: an update. Diabetes Res Clin Pract (2012) 98:26-32. doi:10.1016/j.diabres.2012.05.023.
39. Li B, Li J, Hsieh C-S, Hale LP, Li Y-J, Devlin BH, et al. Characterization of cultured thymus tissue used for transplantation with emphasis on promiscuous expression of thyroid tissue-specific genes. Immunol Res (2009) 44:71-83. doi:10.1007/s12026-008-8083-4.
40. Sabater L, Ferrer-Francesch X, Sospedra M, Caro P, Juan M, Pujol-Borrell R. Insulin alleles and autoimmune regulator (AIRE) gene expression both influence insulin expression in the thymus. J Autoimmun (2005) 25:312-8. doi:10.1016/j.jaut.2005.08.006.
41. Colobran R, Armengol MDP, Faner R, Gärtner M, Tykocinski L-O, Lucas A, et al. Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Hum Mol Genet (2011) 20:3415-23. doi:10.1093/hmg/ddr247.
42. McLachlan SM, Aliesky HA, Chen C-R, Chong G, Rapoport B. Breaking tolerance in transgenic mice expressing the human TSH receptor A-subunit: thyroiditis, epitope spreading and adjuvant as a "double edged sword". PLoS One (2012) 7:e43517. doi:10.1371/journal.pone.0043517.
43. Doyle HA, Mamula MJ. Posttranslational modifications of self-antigens. Ann N Y Acad Sci (2005) 1050:1-9. doi:10.1196/annals.1313.001.
44. Doyle HA, Mamula MJ. Autoantigenesis: the evolution of protein modifications in autoimmune disease. Curr Opin Immunol (2012) 24:112-8. doi:10.1016/j.coi.2011.12.003.
45. Michaëlsson E, Malmström V, Reis S, Engström A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med (1994) 180:745-9. doi:10.1084/jem.180.2.745.
46. Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 191:603-12. doi:10.1084/jem.191.4.603.
47. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest (1998) 101:273-81. doi:10.1172/JCI1316.
48. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol (2003) 171:538-41.
49. Champion BR, Page KR, Parish N, Rayner DC, Dawe K, Biswas-Hughes G, et al. Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med (1991) 174:363-70. doi:10.1084/jem.174.2.363.
50. Van Stipdonk MJ, Willems AA, Amor S, Persoon-Deen C, Travers PJ, Boog CJ, et al. T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. Int Immunol (1998) 10:943-50. doi:10.1093/intimm/10.7.943.
51. Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, Lührmann R. The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem (2000) 275:17122-9. doi:10.1074/jbc.M000300200.
52. Anderton SM. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol (2004) 16:753-8. doi:10.1016/j.coi.2004.09.001.
53. Van Lummel M, Zaldumbide A, Roep BO. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes (2013) 20:299-306. doi:10.1097/MED.0b013e3283631417.
54. Cao L, Goodin R, Wood D, Moscarello MA, Whitaker JN. Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry (1999) 38:6157-63. doi:10.1021/bi982960s.
55. Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry (2000) 39:5374-81. doi:10.1021/bi9925569.
56. Pritzker LB, Joshi S, Harauz G, Moscarello MA. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase. Biochemistry (2000) 39:5382-8. doi:10.1021/bi9925571.
57. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol (2010) 22:293-8. doi:10.1097/BOR.0b013e328336ba63.
58. Dai YD, Rao VP, Carayanniotis G. Enhanced iodination of thyroglobulin facilitates processing and presentation of a cryptic pathogenic peptide. J Immunol (2002) 168:5907-11.
59. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 2:1111-5. doi:10.1016/S0140-6736(83)90628-1.
60. Pujol-Borrell R, Hanafusa T, Chiovato L, Bottazzo GF. Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature (1983) 304:71-3. doi:10.1038/304071a0.
61. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet (1983) 2:1115-9. doi:10.1016/S0140-6736(83)90629-3.
62. Londei M, Lamb JR, Bottazzo GF, Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature (1984) 312:639-41. doi:10.1038/312639a0.
63. Pujol-Borrell R, Soldevila G, Buscema M, Vives M, Badenas J, Marakian R, et al. Inappropriate expression of HLA class II molecules in endocrine epithelial cells: the phenomenon, the new experimental data and comparison with animal models. J Autoimmun (1989) 2(Suppl):163-9. doi:10.1016/0896-8411(89)90127-3.
64. Davies TF. The complex role of epithelial cell MHC class II antigen expression in autoimmune endocrine disease. Autoimmunity (1990) 8:87-9. doi:10.3109/08916939008995725.
65. Walter U, Toepfer T, Dittmar KEJ, Kretschmer K, Lauber J, Weiss S, et al. Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes. Diabetologia (2003) 46:1106-14. doi:10.1007/s00125-003-1164-y.
66. Catálfamo M, Serradell L, Roura-Mir C, Kolkowski E, Sospedra M, Vives-Pi M, et al. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. Int Immunol (1999) 11:269-77. doi:10.1093/intimm/11.2.269.
67. Suri A, Levisetti MG, Unanue ER. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr Opin Immunol (2008) 20:105-10. doi:10.1016/j.coi.2007.10.007.
68. Sette A, Southwood S, Miller J, Appella E. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J Exp Med (1995) 181:677-83. doi:10.1084/jem.181.2.677.
69. Fallang L-E, Roh S, Holm A, Bergseng E, Yoon T, Fleckenstein B, et al. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM. J Immunol (2008) 181:5451-61.
70. Hou T, MacMillan H, Chen Z, Keech CL, Jin X, Sidney J, et al. An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations. J Immunol (1950) 2011(187):2442-52. doi:10.4049/jimmunol.1100255.
71. Van Lummel M, van Veelen PA, Zaldumbide A, de Ru A, Janssen GMC, Moustakas AK, et al. Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem (2012) 287:9514-24. doi:10.1074/jbc.M111.313940.
72. Mohan JF, Unanue ER. A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity. Mol Immunol (2013) 55:166-8. doi:10.1016/j.molimm.2012.10.024.
73. Mohan JF, Levisetti MG, Calderon B, Herzog JW, Petzold SJ, Unanue ER. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol (2010) 11:350-4. doi:10.1038/ni.1850.
74. Mohan JF, Petzold SJ, Unanue ER. Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion. J Exp Med (2011) 208:2375-83. doi:10.1084/jem.20111502.
75. Kawamura K, McLaughlin KA, Weissert R, Forsthuber TG. Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J Immunol (2008) 181:3202-11.